BioAtla LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BioAtla LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10924
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioAtla LLC (BioAtla) is a biotechnology company that develops novel monoclonal antibodies and other cell based therapeutics. The company utilizes proprietary conditionally active biologics and comprehensive integrated antibody optimization platforms to develop novel therapies. It develops drugs for various cancer indications such as NSCLC, breast, pancreatic, ovarian, aml, liver, esophageal and prostate. BioAtla partners with other organizations to advance a CAB immune checkpoint inhibitor and the selected CAB-ADCs into commercial products. The company offers laboratories in the US and China. BioAtla is headquartered in San Diego, California, the US.

BioAtla LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioAtla LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioAtla LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioAtla LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioAtla LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
BioAtla Raises USD3 Million in Venture Financing 11
Partnerships 12
BioAtla Expands its Agreement with Beijing Sinobioway 12
BioAtla Enters into Co-Development Agreement with BioDuro 13
BioAtla And EpiVax Partner For Antibody Screening Technology 14
Licensing Agreements 15
F1 Oncology Enters into Licensing Agreement with BioAtla 15
Pfizer Enters into Licensing Agreement with BioAtla 16
BioAtla Enters Into Licensing Agreement With BioMotiv 17
ADC Therapeutics Enters Into Licensing Agreement With VivaMab For VM101 18
Equity Offering 19
BioAtla to Raise USD45 Million in Financing 19
BioAtla Raises USD30 Million in Private Placement of Shares 20
BioAtla LLC – Key Competitors 21
BioAtla LLC – Key Employees 22
BioAtla LLC – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Corporate Communications 24
Sep 10, 2018: BioAtla names Scott Smith as President 24
Jul 24, 2018: BioAtla names Lawrence Fong as scientific advisor 25
May 09, 2017: BioAtla Appoints Yong Ben, M.D., As Chief Medical Officer 26
Clinical Trials 27
Jan 24, 2018: BioAtla Announces FDA Clearance of IND Application for CAB-AXL-ADC Therapeutic 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
BioAtla LLC, Pharmaceuticals & Healthcare, Key Facts 2
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioAtla LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioAtla LLC, Deals By Therapy Area, 2012 to YTD 2018 8
BioAtla LLC, Medical Devices Deals, 2012 to YTD 2018 9
BioAtla LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioAtla Raises USD3 Million in Venture Financing 11
BioAtla Expands its Agreement with Beijing Sinobioway 12
BioAtla Enters into Co-Development Agreement with BioDuro 13
BioAtla And EpiVax Partner For Antibody Screening Technology 14
F1 Oncology Enters into Licensing Agreement with BioAtla 15
Pfizer Enters into Licensing Agreement with BioAtla 16
BioAtla Enters Into Licensing Agreement With BioMotiv 17
ADC Therapeutics Enters Into Licensing Agreement With VivaMab For VM101 18
BioAtla to Raise USD45 Million in Financing 19
BioAtla Raises USD30 Million in Private Placement of Shares 20
BioAtla LLC, Key Competitors 21
BioAtla LLC, Key Employees 22
BioAtla LLC, Subsidiaries 23

List of Figures
BioAtla LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BioAtla LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BioAtla LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BioAtla LLC, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[BioAtla LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AMC Entertainment Holdings, Inc.:企業の戦略・SWOT・財務分析
    AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Actuant Corporation (ATU):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Actuant Corporation" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follo …
  • Preformed Line Products Company (PLPC):企業概要、財務及び戦略的SWOT分析
    Summary Preformed Line Products Company (PLP) is an energy product manufacturing company. The company designs, manufactures and supplies cable anchoring and control hardware and systems, fiber optic and copper splice closures, and speed cross-connect devices. It offers fiber optics, copper, demarcat …
  • to-BBB technologies BV:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' to-BBB technologies BV Mergers …
  • Tetraphase Pharmaceuticals Inc (TTPH):企業財務及び戦略的SWOT分析
    Summary Tetraphase Pharmaceuticals Inc (Tetraphase) is a clinical stage life science company that discovers and develops antibiotic resistance medicines. The company’s products under clinical development include eravacycline, TP-271, and TP-6076. It develops products for the treatment of respiratory …
  • Neuravi Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Neuravi Ltd (Neuravi) is a medical device company that develops and commercializes endovascular devices and stroke treatment. The company provides embotrap revascularization device which is a thrombectomy system designed with clot-device mechanics to address challenging occlusions. Its embot …
  • MYR Group Inc. (MYRG):企業の財務及び戦略的SWOT分析
    Summary MYR Group Inc. (MYR Group) is an electrical contractor. The company is a specialty contractor for commercial, industrial and electrical infrastructure markets. It classifies its business into two segments, transmission and distribution (T&D), and commercial and industrial (C&I) electrical co …
  • William Ransom and Son plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' William Ransom and Son plc Merg …
  • Canada Zinc Metals Corp. (CZX):企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Canada Zinc Metals Corp." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly …
  • Mosenergo (MSNG):電力:M&Aディール及び事業提携情報
    Summary Mosenergo, a subsidiary of Gazprom Energoholding LLC, is a power utility. It generates electricity and thermal energy using natural gas, coal, fuel oil, and diesel sources. The company owns and operates power plants: TPP-20, SDPP-3, TPP-9, SPP-1, TPP-21, TPP-8, TPP-11, TPP-16, TPP-12, TPP-17 …
  • American Water Works Company, Inc.:企業の戦略・SWOT・財務情報
    American Water Works Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Water Works Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Esperi Care Oy:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Esperi Care Oy Mergers and Acqu …
  • Baker Hughes Incorporated:企業の戦略・SWOT・財務情報
    Baker Hughes Incorporated - Strategy, SWOT and Corporate Finance Report Summary Baker Hughes Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sharp Corporation (6753):企業のM&A・提携動向(エネルギー分野)
    Summary Sharp Corporation (Sharp) carries out designing, development, manufacturing, and marketing of digital information equipments, health and environmental equipments, energy and business solutions. The company’s key products include refrigerators, microwave ovens, air conditioners, washing machi …
  • Hadasit Bio-Holdings Ltd. (HDST):企業概要、財務及び戦略的SWOT分析
    Summary Hadasit Bio-Holdings Ltd. (Hadasit) is a biotechnology company. The company provides biotech financing, research and development, promoting and commercializing the intellectual property services in the biotechnology field. It funds the preparation for and execution of phase I and preparation …
  • Blue Apron Inc. (APRN):企業の財務・戦略的SWOT分析
    Blue Apron Inc. (APRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Synlogic Inc (SYBX):製薬・医療:M&Aディール及び事業提携情報
    Summary Synlogic Inc (Synlogic), formerly TMC Therapeutics Inc is a clinical stage drug development company that develops novel class of living medicines for the treatment of rare and genetic metabolic diseases, by applying synthetic biology to probiotics. The company’s pipeline includes SYNB1020 a …
  • EnGeneIC Ltd-製薬・医療分野:企業M&A・提携分析
    Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference m …
  • Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析
    Summary Baylor Scott & White Health (Baylor Scott & White) is a non-profit organization that provides medical care services. The organization provides medical education, medical services and conducts medical research. It offers medical services in the area of emergency care, cancer care, behavioral …
  • Syngen Biotech Co Ltd (8279):製薬・医療:M&Aディール及び事業提携情報
    Summary Syngen Biotech Co Ltd (Syngen) is a biotechnology company. The company manufactures and supplies active pharmaceutical ingredients (APIs), biology fermentation products, nutritional ingredients, nutraceutical ingredients, biology agriculture and aquaculture products, and functional food prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆